Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MRC Delivering on the Life Sciences Strategy, One Year On

Published: Tuesday, December 11, 2012
Last Updated: Tuesday, December 11, 2012
Bookmark and Share
The Medical Research Council has made significant progress in implementing the measures outlined in last year’s Strategy for UK Life Sciences, according to a progress update published by the Government.

The Strategy for UK Life Sciences: One Year On report summarises the progress made in the 12 months since the strategy was launched and also announces a number of new measures, including a £20 million investment in regenerative medicine as part of the £600m science capital funding unveiled in the Government’s Autumn Statement earlier this month.

Among the successes has been the establishment of the MRC/Technology Strategy Board Biomedical Catalyst, which so far has committed £49m to 64 projects. This will leverage at least £25m of private sector funding. The Catalyst is designed to support academics and businesses to explore the market potential of their early-stage scientific ideas, and accelerate the development of innovative solutions to healthcare challenges.

The update also highlights recent MRC funding of £7m for 15 research projects awarded through its groundbreaking ‘compound collaboration’ with AstraZeneca. This was the first scheme of its kind, and gave scientists access to 22 AstraZeneca compounds which are now being used by academics to study a broad range of conditions from diseases like Alzheimer’s, cancer and lung disease through to rarer conditions such as motor neurone disease and muscular dystrophies. In November 2012, this ground-breaking initiative won ‘Best Partnership Alliance’ at the annual SCRIP Awards event in London.

Other initiatives by the MRC included in the One Year On report are:

•    An investment of £60m over three years through the MRC Experimental Medicine Challenge Grants. A large number of outline applications have been received and 30 full-stage applications are now being assessed through rigorous international peer review.
•    £9.6m provided for the expansion of UK Biobank. This will include 8,000 brain scans, and one project aims to help scientists discover why some people develop dementia and others do not.
•    An investment of £10.6m in three large-scale collaborative awards under the MRC’s Stratified Medicine Initiative. These stratified medicine consortia will tackle diseases which have a huge impact on patient’s lives – rheumatoid arthritis, hepatitis C and a rare condition called Gaucher disease. This builds on £11.5 investment in pilot consortia focusing on chronic obstructive pulmonary disease, rheumatoid arthritis and diabetes (the MASTERMIND consortia).
•    A joint commitment by the MRC, the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council to jointly invest £25m over five years to maximise the potential of the Cell Therapy Catapult.
•    A consortium of 10 UK government and charity research funders led by the MRC has awarded £19m to four e-health research Centres of Excellence based in London, Manchester, Dundee and Swansea.
•    The MRC-NIHR Phenome Centre, which will analyse thousands of samples of blood, urine and tissue to discover how our genes interact with our environment to cause and affect the course of disease, will open at Imperial College London in 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genetic Signature Linked to Cancer Prognosis Identified
The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
Monday, October 10, 2016
Potential Urine Test for CJD
Researchers at the Medical Research Council (MRC) Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
Tuesday, October 04, 2016
Genes Essential to Life Discovered
Genes critical for life are discovered in humans and mice as part of large-scale phenotyping study.
Thursday, September 15, 2016
Gene Linked to Hearing Loss Identified
Researchers have identifed a gene associated with age-related hearing loss.
Monday, August 22, 2016
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
Monday, August 22, 2016
Discovery of Key Component of HIV Yields New Drug Target
Scientists from the MRC Laboratory of Molecular Biology in Cambridge and University College London have discovered an essential feature of HIV that the virus uses to infect cells whilst avoiding detection by the immune system. This discovery presents a new drug target and the opportunity to re-evaluate existing treatments for HIV to improve their efficacy.
Thursday, August 11, 2016
MRC Technology, Alzheimer’s Association Collaborate
MRC Technology (MRCT), an independent medical research charity based in London, and the Alzheimer’s Association in Chicago have entered into an agreement to review and monitor the Association’s grant-funded research portfolio.
Thursday, January 21, 2016
Study Shows Blocking Brain Inflammation Could Help Alzheimer's
The research was jointly funded by the Medical Research Council (MRC) and Alzheimer’s Research UK.
Saturday, January 09, 2016
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.
Wednesday, September 30, 2015
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Wednesday, July 22, 2015
MRC, GSK and Five Leading UK Universities Collaborate
Collaboration to crack difficult disease areas.
Thursday, July 16, 2015
‘Mini Bile Ducts’ used to Discover New Drugs that could Prevent Liver Damage
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Tuesday, July 14, 2015
First RNAi Meiosis Screen Reveals Genes Essential to Generate Eggs
Screening techniques developed leading to the discovery of genes essential for meiosis in mammals.
Wednesday, July 08, 2015
Study Identifies New Way to Kill the Malaria Parasite
Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could pave the way to new treatments for the disease.
Tuesday, July 07, 2015
Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Tuesday, November 11, 2014
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!